Sanghvi Brands Ltd vs Sheel Biotech Ltd Stock Comparison
Sanghvi Brands Ltd vs Sheel Biotech Ltd Stock Comparison
Last Updated on: Mar 13, 2026
Key Highlights
The Latest Trading Price of Sanghvi Brands Ltd is ₹ 11 as of 13 Mar 15:30
. The P/E Ratio of Sanghvi Brands Ltd changed from 38.3 on March 2024 to 10.6 on March 2025 . This represents a CAGR of -47.39% over 2 yearsThe P/E Ratio of Sheel Biotech Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Sanghvi Brands Ltd changed from ₹ 11.44 crore on March 2021 to ₹ 10.73 crore on March 2025 . This represents a CAGR of -1.27% over 5 yearsThe Market Cap of Sheel Biotech Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 years The Dividend Payout of Sanghvi Brands Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Sheel Biotech Ltd changed from 28.46 % on March 2022 to 14.05 % on March 2025 . This represents a CAGR of -16.18% over 4 years .
About Sanghvi Brands Ltd
Sanghvi Brands Limited was incorporated as a Private Limited Company with the name 'Sanghvi Brands Promoters Private Limited' on February 16, 2010.
Subsequently, the Company name changed from Sanghvi Brands Promoters Private Limited to Sanghvi Brands Private Limited on February 21, 2017.
Further, the status of the Company got converted into Public Limited Company and the name was retained as 'Sanghvi Brands Limited' on July 21, 2017.
The Company manages & operates one of India's leading integrated portfolio of Luxury Spa, Beauty, Wellness & Fitness Brands and one of the Top Largest Spa & Wellness Operators in India with license rights to operate various Premium International Brands including: Spa by Clarins, Spa by L'Occitane, Elle Spas & Salons, Warren Tricomi Salon & Spas, Rosanno Ferretti Salon, Ramona Braganza's 3-2-1 Fitness Programme, The Company has sole distributorship of Noveau Lashes for the territory of India to promote, market and sell these products.
About Sheel Biotech Ltd
Sheel Biotech Limited was incorporated as a Private Company as 'Sheel Biotech Private Limited' dated November 26, 1991, with the Registrar of Companies, Delhi & Haryana.
Further, Company was converted into a Public Limited Company w.e.f.
April 02, 1992.
The Company was founded by Dr. Satya Narayan Chandak in 1991.
Thereafter, through his vision he led the stone of Tissue Culture lab wherein for advancement of lab he deputed two of his scientists to Netherlands for training to expand the business ventured in domestic market too and then added greenhouse division to promote protected cultivation.
The Company started the Import division in 2019 and importing tulip, glad, lilium, orchids and alstromeria.
FAQs for the comparison of Sanghvi Brands Ltd and Sheel Biotech Ltd
Which company has a larger market capitalization, Sanghvi Brands Ltd or Sheel Biotech Ltd?
Market cap of Sanghvi Brands Ltd is 11 Cr while Market cap of Sheel Biotech Ltd is 110 Cr
What are the key factors driving the stock performance of Sanghvi Brands Ltd and Sheel Biotech Ltd?
The stock performance of Sanghvi Brands Ltd and Sheel Biotech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.
What are the recent stock price for Sanghvi Brands Ltd and Sheel Biotech Ltd?
As of March 13, 2026, the Sanghvi Brands Ltd stock price is INR ₹11.1. On the other hand, Sheel Biotech Ltd stock price is INR ₹54.5.
How do dividend payouts of Sanghvi Brands Ltd and Sheel Biotech Ltd compare?
To compare the dividend payouts of Sanghvi Brands Ltd and Sheel Biotech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.